106 results
Page 5 of 6
6-K
n0m7 gbpabal
18 Dec 18
Current report (foreign)
4:05pm
6-K
EX-99.1
513h2k7 9lidfsvyc
15 Oct 18
Notice of Annual General Meeting of Shareholders
8:15am
6-K
EX-99.2
yd6xqrcis09 5k
15 Oct 18
Notice of Annual General Meeting of Shareholders
8:15am
424B5
dx8h kotnx0vu
27 Jun 18
Prospectus supplement for primary offering
9:30am
6-K
8ate7utpo svincfq
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
6-K
EX-1.1
dgzyhnpnk
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
20-F/A
EX-4.3
nzs43zy1t4e8902uh xl
11 Oct 17
Annual report (foreign) (amended)
12:00am
6-K
hmno1ejuwnnir
21 Apr 15
Current report (foreign)
12:00am
20-F
EX-4.18
ts7940d
25 Mar 15
Annual report (foreign)
12:00am
20-F
nsa4dj4
25 Mar 15
Annual report (foreign)
12:00am
424B4
37v56t2tt00ao
2 Oct 14
Prospectus supplement with pricing info
12:00am
424B4
7ousma7jcb1zy3l2s
1 Aug 14
Prospectus supplement with pricing info
12:00am
F-1/A
EX-10.3
ryfyw x7z61i2ps2sr
18 Jul 14
Registration statement (foreign) (amended)
12:00am